Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 19511-19520 Newer>

The Motley Fool December 29, 2006 Brian Lawler	Lilly's Patents Stay in Bloom Even with upcoming patent expiries, Lilly isn't in nearly the same desperate situation that some of its large-cap pharma peers will be dealing with in the upcoming years. Investors, take note.
The Motley Fool December 29, 2006 David Lee Smith	El Paso Gets Back to Basics The energy company's New Year's resolution? Concentrate on the core. Energy will be an extremely active sector for years to come. Investors, take note.
The Motley Fool December 29, 2006 Brian Lawler	InterMune Gets Ready to Sell Shares For investors' sake, getting any necessary dilution over and done with at higher share prices means fewer shares of the diluting financing need to be issued, so it's smart that InterMune is getting ready to sell shares now in case more positive clinical trial results cause shares to spike.
The Motley Fool December 29, 2006 Brian Lawler	SciClone Sees Opportunity in the Far East Pharma SciClone goes about gaining regulatory approval the opposite way from most -- through China. This isn't such a bad idea, considering that drug sales in China grew 20% last year. Investors, take note.
The Motley Fool December 29, 2006 Brian Lawler	Sirna Decides to Take the Cash and Run Shareholders vote to approve Merck's buyout offer. Investors in shares of Merck really have to trust management to have done its due diligence on Sirna and to have faith in its technology.
The Motley Fool December 29, 2006 Rick Aristotle Munarriz	2006 in Review: Baidu China and the Internet sound like delicious ingredients for a growth stock recipe, and Baidu has certainly proven tasty.
BusinessWeek January 8, 2007 Mara Der Hovanesian	EMC: A Fresh Tech Star EMC is a favorite, and the stock is up from an Aug. 9 low.
BusinessWeek January 8, 2007 Mara Der Hovanesian	Green Mountain Could Really Percolate Green Mountain Coffee Roasters has been called the best retail story out there.
BusinessWeek January 8, 2007 Mara Der Hovanesian	What's Powering Linear Technology Linear has the highest profit margins in the semiconductor industry, and the company will soon be first on the market with a new series of signal-processing chips for high-growth markets
The Motley Fool December 29, 2006 Brian Lawler	Third Time's the Charm for Encysive? It seems like every other week we hear about a new delay for Encysive's lead drug Thelin. With shares of Encysive down more than 20% yesterday, investors can only hope that the third time is the charm for Thelin's approval from the FDA.
<Older 19511-19520 Newer> Return to current articles.